INVO Bioscience, Inc. (95)
Browse by Contract Category
Contracts
-
Registration Rights Agreement
(Filed With SEC on March 23, 2023)
-
TA Letter dated February 17, 2023
(Filed With SEC on February 23, 2023)
-
Distribution Agreement with Ming Mei Technology Co. Ltd
(Filed With SEC on January 5, 2023)
-
Lease Agreement
(Filed With SEC on May 26, 2022)
-
JV IP License Agreement
(Filed With SEC on June 30, 2021)
-
Employment Agreement
(Filed With SEC on June 15, 2021)
-
HRCFG INVO LLC limited liability company agreement
(Filed With SEC on March 15, 2021)
-
Joint Venture Agreement (Macedonia)
(Filed With SEC on November 25, 2020)
-
Securities Purchase Agreement
(Filed With SEC on March 23, 2023)
-
Form of Warrant
(Filed With SEC on March 23, 2023)
-
Form of Convertible Promissory Note
(Filed With SEC on March 23, 2023)
-
Membership Interest Purchase Agreement dated March 16, 2023 by and among Wood Violet Fertility LLC, a Delaware limited liability company, Fertility Labs of Wisconsin, LLC, a...
(Filed With SEC on March 20, 2023)
-
Asset Purchase Agreement dated March 16, 2023, by and among Wood Violet Fertility LLC, a Delaware limited liability company, Wisconsin Fertility and Reproductive Surgery...
(Filed With SEC on March 20, 2023)
-
Membership Interest Purchase Agreement dated March 16, 2023 by and among Wood Violet Fertility LLC, a Delaware limited liability company, Fertility Labs of Wisconsin, LLC, a...
(Filed With SEC on March 20, 2023)
-
Asset Purchase Agreement dated March 16, 2023, by and among Wood Violet Fertility LLC, a Delaware limited liability company, Wisconsin Fertility and Reproductive Surgery...
(Filed With SEC on March 20, 2023)
-
Debenture dated February 17, 2023
(Filed With SEC on February 23, 2023)
-
Warrant dated February 17, 2023
(Filed With SEC on February 23, 2023)
-
Securities Purchase Agreement dated February 17, 2023 (Debenture and Warrant)
(Filed With SEC on February 23, 2023)
-
Registration Rights Agreement dated February 3, 2023 (Equity Purchase Agreement)
(Filed With SEC on February 9, 2023)
-
Equity Purchase Agreement dated February 3, 2023
(Filed With SEC on February 9, 2023)
-
TA Letter dated February 3, 2023
(Filed With SEC on February 9, 2023)
-
Registration Rights Agreement dated February 3, 2023 (Debenture and Warrant)
(Filed With SEC on February 9, 2023)
-
Securities Purchase Agreement dated February 3, 2023 (Debenture and Warrant)
(Filed With SEC on February 9, 2023)
-
Securities Purchase Agreement dated February 3, 2023 (Debenture and Warrant)
(Filed With SEC on February 9, 2023)
-
Securities Purchase Agreement dated February 3, 2023 (Debenture and Warrant)
(Filed With SEC on February 9, 2023)
-
Warrant dated December 29, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC
(Filed With SEC on January 5, 2023)
-
Letter Agreement between INVO Bioscience, Inc. and JAG Multi Investments LLC
(Filed With SEC on January 5, 2023)
-
Demand Promissory Note dated December 29, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC in the amount of $100,000
(Filed With SEC on January 5, 2023)
-
Form of Convertible Promissory Note
(Filed With SEC on January 5, 2023)
-
Form of Warrant
(Filed With SEC on January 5, 2023)
-
Securities Purchase Agreement
(Filed With SEC on January 5, 2023)
-
Registration Rights Agreement
(Filed With SEC on January 5, 2023)
-
Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC in the amount of $50,000
(Filed With SEC on December 19, 2022)
-
Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of Andax LLC in the amount of $25,000
(Filed With SEC on December 19, 2022)
-
Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $25,000
(Filed With SEC on December 19, 2022)
-
Demand Promissory Note dated December 2, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $15,000
(Filed With SEC on December 5, 2022)
-
Demand Promissory Note dated November 29, 2022 issued by INVO Bioscience, Inc. in favor of Andax LLC in the amount of $75,000
(Filed With SEC on December 5, 2022)
-
Demand Promissory Note dated November 29, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $60,000
(Filed With SEC on December 5, 2022)
-
Form of Demand Note
(Filed With SEC on November 14, 2022)
-
Exclusive Distribution Agreement
(Filed With SEC on May 16, 2022)
-
Termination Notice to Paradigm Opportunities Fund, LP dated March 30, 2022
(Filed With SEC on March 31, 2022)
-
Termination Notice to Medesole Healthcare and Trading Private Limited dated March 29, 2022
(Filed With SEC on March 31, 2022)
-
Description of Capital Stock
(Filed With SEC on March 31, 2022)
-
Third Amendment to Stock Purchase Agreement
(Filed With SEC on February 2, 2022)
-
Second Amendment to Stock Purchase Agreement
(Filed With SEC on January 6, 2022)
-
Amendment to Stock Purchase Agreement
(Filed With SEC on December 2, 2021)
-
INVOcell Supply Agreement
(Filed With SEC on December 2, 2021)
-
Termination Notice
(Filed With SEC on November 8, 2021)
-
Form of Placement Agent Warrant to Purchase Common Stock
(Filed With SEC on October 5, 2021)
-
Form of Securities Purchase Agreement, dated October 1, 2021, between the Company and the purchasers party thereto
(Filed With SEC on October 5, 2021)
-
Placement Agent Agreement, dated October 1, 2021, between the Company and the Placement Agent
(Filed With SEC on October 5, 2021)
-
Stock Purchase Agreement
(Filed With SEC on October 4, 2021)
-
Share Purchase Agreement
(Filed With SEC on September 7, 2021)
-
Guarantee of Sublease
(Filed With SEC on June 30, 2021)
-
Guarantee of Sublease
(Filed With SEC on June 30, 2021)
-
INVO IP Sublicense Agreement
(Filed With SEC on June 30, 2021)
-
INVOcell Supply Agreement
(Filed With SEC on June 30, 2021)
-
Management Services Agreement
(Filed With SEC on June 30, 2021)
-
LLC Agreement
(Filed With SEC on June 30, 2021)
-
JV Agreement
(Filed With SEC on June 30, 2021)
-
Lease agreement dated March 17, 2021 between INVO Bioscience, Inc, Trustmark National Bank and HRCFG, LLC
(Filed With SEC on May 17, 2021)
-
Partnership Agreement
(Filed With SEC on April 13, 2021)
-
Lease, dated March 2021, with Trustmark National Bank
(Filed With SEC on March 30, 2021)
-
Description of Capital Stock
(Filed With SEC on March 30, 2021)
-
Press Release dated March 15, 2021
(Filed With SEC on March 15, 2021)
-
Amendment No. 1 to Distribution Agreement
(Filed With SEC on March 8, 2021)
-
Distribution Agreement
(Filed With SEC on December 8, 2020)
-
Joint Venture Agreement (Malaysia)
(Filed With SEC on November 25, 2020)
-
Distribution Agreement
(Filed With SEC on November 25, 2020)
-
Underwriting Agreement, dated November 12, 2020, by and between the Company and Roth Capital Partners, LLC
(Filed With SEC on November 13, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on November 9, 2020)
-
Pre-Incorporation and Shareholders Agreement
(Filed With SEC on September 30, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on September 21, 2020)
-
Securities Purchase Agreement
(Filed With SEC on June 26, 2020)
-
Placement Agent Agreement
(Filed With SEC on June 26, 2020)
-
Form of Unit Purchase Option
(Filed With SEC on June 26, 2020)
-
Form of Secured Convertible Note
(Filed With SEC on June 26, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on May 15, 2020)
-
Form of Security Agreement
(Filed With SEC on May 15, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on May 15, 2020)
-
Form of Warrant
(Filed With SEC on May 15, 2020)
-
Form of Unit Purchase Option
(Filed With SEC on May 15, 2020)
-
Form of Secured Convertible Note
(Filed With SEC on May 15, 2020)
-
Commercial Lease Agreement dated May 1, 2019 between the registrant and PJ LLC
(Filed With SEC on March 30, 2020)
-
Employment Agreement, dated January 15, 2020
(Filed With SEC on January 21, 2020)
-
Joint Venture Agreement, dated January 13, 2020, between INVO Bioscience, Inc. and Medesole Healthcare and Trading Private Limited, India
(Filed With SEC on January 16, 2020)
-
Agreement for Release of Claims and Stock Option dated October 29, 2019 with James Bowdring
(Filed With SEC on November 14, 2019)
-
Agreement for Release of Claims and Stock Option dated October 29, 2019 with Kathleen Karloff
(Filed With SEC on November 14, 2019)
-
Settlement Agreement and General Release dated November 11, 2019
(Filed With SEC on November 14, 2019)
-
Employment Offer Letter with Steve Shum
(Filed With SEC on October 15, 2019)
-
Promissory Note August 2016
(Filed With SEC on April 16, 2019)
-
CONVERTIBLE NOTE PURCHASE AGREEMENT
(Filed With SEC on April 16, 2019)
-
Form of Convertible Note Purchase Agreement 2018
(Filed With SEC on April 16, 2019)
-
Supply Agreement between the INVO Bioscience, Inc and Ferring International Center S.A
(Filed With SEC on April 16, 2019)
-
Form of Convertible Promissory Note 2018
(Filed With SEC on April 16, 2019)